Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14521-96-1

Post Buying Request

14521-96-1 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

14521-96-1 Usage

Chemical Properties

White, crystalline powder

Uses

Etorphine is used as a narcotic analgesic.

Check Digit Verification of cas no

The CAS Registry Mumber 14521-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,5,2 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 14521-96:
(7*1)+(6*4)+(5*5)+(4*2)+(3*1)+(2*9)+(1*6)=91
91 % 10 = 1
So 14521-96-1 is a valid CAS Registry Number.
InChI:InChI=1/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1

14521-96-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name etorphine

1.2 Other means of identification

Product number -
Other names Oripavine,6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14521-96-1 SDS

14521-96-1Relevant articles and documents

IMPROVED METHOD OF MANUFACTURING BUPRENORPHINE AND ANALOGUES THEREOF FROM ORIPAVINE

-

Page/Page column 26, (2016/06/15)

The invention relates to an improved method of preparing buprenorphine, a salt thereof, analogues of buprenorphine and their salts. In particular, the invention relates to a method of preparing buprenorphine and related products and salts in economic and ecologic ways having increased yields.

Combination of selected opioids with muscarine antagonists for treating urinary incontinence

-

, (2008/06/13)

Active compound combinations of compounds of group A, particularly opioids, and compounds of group B, particularly anti-muscarine agents and other substances suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.

Synthesis of the novel sulfur-containing analgesic S-etorphine

Hori,Kataoka,Shimizu,et al.

, p. 1268 - 1271 (2007/10/02)

-